Family Care Hospitals Posts ₹44 Cr Loss, Revenue Just ₹7.9 Cr in FY26

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
Family Care Hospitals Posts ₹44 Cr Loss, Revenue Just ₹7.9 Cr in FY26
Overview

Family Care Hospitals Ltd reported a net loss of ₹44.15 crore for the fiscal year ended March 31, 2026, with revenue at just ₹7.90 crore. The company also announced the resignation of its Company Secretary and the initiation of a postal ballot process.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Family Care Hospitals Reports ₹44 Cr Loss in FY26 with Revenue at ₹7.9 Cr

Family Care Hospitals Ltd reported a net loss of ₹44.15 crore for the fiscal year ended March 31, 2026. Revenue from operations for the period stood at ₹7.90 crore.

Financial Results and Key Announcements

The company's audited standalone financial results for fiscal year 2026 show a net loss of ₹44.15 crore. Revenue from operations reached ₹7.90 crore, with total expenses at ₹19.10 crore and total income at ₹11.06 crore.

In parallel, Family Care Hospitals announced the resignation of Mrs. Neetu Maurya as Company Secretary and Compliance Officer, effective May 2, 2026. A postal ballot process has also been approved by the company.

Implications of Recent Events

The substantial net loss highlights ongoing financial pressures for Family Care Hospitals, potentially affecting investor confidence and operational stability. The departure of a key officer like the Company Secretary suggests potential management changes and necessitates a swift appointment to maintain governance. The upcoming postal ballot process will involve crucial shareholder votes on company resolutions, impacting its future direction.

Company Overview

Family Care Hospitals operates a chain of healthcare facilities offering medical and diagnostic services.

Current Situation

Shareholders are facing continued financial underperformance and a key management vacancy. The company's future direction will depend significantly on upcoming shareholder approvals via the postal ballot, underscoring the importance of corporate governance.

Risks and Uncertainties

The company faces operational continuity and data integrity risks following a ransomware attack in January 2026, although control measures have been strengthened. There is also uncertainty regarding the realization of ₹38.03 crore in unutilised Discount Coupon Vouchers, which depends on hospital operations reviving.

Peer Performance Comparison

Competitors such as Apollo Hospitals Enterprise Ltd and Max Healthcare Institute Ltd operate on a considerably larger scale. In comparison, these peers reported strong profits, with Apollo Hospitals posting ₹1,240 crore and Max Healthcare ₹1,000 crore in Profit After Tax for FY24.

Key Financial Metrics

  • FY26 (Standalone): Revenue from Operations was ₹790.46 lakh (₹7.90 crore), Net Loss was ₹4,414.53 lakh (₹44.15 crore), and Basic/Diluted EPS was ₹(1.61).
  • Q4 FY26 (Standalone): Revenue from Operations was ₹5.86 lakh (₹0.06 crore), Net Loss was ₹242.31 lakh (₹2.42 crore), and Basic/Diluted EPS was ₹(0.45).

What to Watch

Investors will be tracking the outcome of the postal ballot vote on key resolutions. Management's strategic plan to tackle the net loss and improve financial performance will also be closely watched, alongside the appointment of a new Company Secretary and Compliance Officer. Progress on utilizing or selling the unutilised Discount Coupon Vouchers is another key area.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.